Universal Ibogaine Inc. (IBOGF)

USD 0.02

(0.0%)

Long Term Debt Summary of Universal Ibogaine Inc.

  • Universal Ibogaine Inc.'s latest annual long term debt in 2022 was 1.73 Million CAD , up 2796.12% from previous year.
  • Universal Ibogaine Inc.'s latest quarterly long term debt in 2023 Q2 was 2.16 Million CAD , up 190.01% from previous quarter.
  • Universal Ibogaine Inc. reported annual long term debt of 60 Thousand CAD in 2021, down 0.0% from previous year.
  • Universal Ibogaine Inc. reported annual long term debt of - CAD in 2020, down 0.0% from previous year.
  • Universal Ibogaine Inc. reported quarterly long term debt of 748.22 Thousand CAD for 2023 Q1, down -56.94% from previous quarter.
  • Universal Ibogaine Inc. reported quarterly long term debt of 2.52 Million CAD for 2023 Q3, up 16.49% from previous quarter.

Annual Long Term Debt Chart of Universal Ibogaine Inc. (2022 - 2017)

Historical Annual Long Term Debt of Universal Ibogaine Inc. (2022 - 2017)

Year Long Term Debt Long Term Debt Growth
2022 1.73 Million CAD 2796.12%
2021 60 Thousand CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%

Peer Long Term Debt Comparison of Universal Ibogaine Inc.

Name Long Term Debt Long Term Debt Difference
Bioxytran, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 91.689%
Intellipharmaceutics International Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -21620.913%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 1.014%
Propanc Biopharma, Inc. 58.64 Thousand USD -2863.188%
Marizyme, Inc. 667.12 Thousand USD -160.47%
Genus plc 228.2 Million USD 99.239%
Pharming Group N.V. 166.1 Million USD 98.954%
Therapeutic Solutions International, Inc. 5512.00 USD -31425.272%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 21.372%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD -23.86%
IMV Inc. 27.39 Million USD 93.658%
AXIM Biotechnologies, Inc. 5.42 Million USD 67.978%
ONE Bio Corp. 592.19 Thousand USD -193.428%
RVL Pharmaceuticals plc 55.61 Million USD 96.875%
Mesoblast Limited 100.29 Million USD 98.267%
MultiCell Technologies, Inc. 36.43 USD -4769795.69%
Arno Therapeutics, Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 21.937%
Genscript Biotech Corporation 287.12 Million USD 99.395%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD -41.463%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -6768.544%
Oncotelic Therapeutics, Inc. 1.89 Million USD 8.47%
Skye Bioscience, Inc. 171.23 Thousand USD -914.818%
GlobeStar Therapeutics Corporation - USD -Infinity%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Accustem Sciences Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD -439.65%
Alpha Cognition Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.985%
Agentix Corp. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD -213.326%
Enzolytics Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -958.234%
MetaStat, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 88.683%
Northwest Biotherapeutics, Inc. 20.31 Million USD 91.445%
HST Global, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -1058.449%
Endonovo Therapeutics, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -38896.252%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -1275.808%
AVAX Technologies, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. 229.29 Thousand USD -657.846%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 78.973%
Kadimastem Ltd 229.69 Thousand USD -656.526%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD -554.158%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -163215.132%
Burzynski Research Institute, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -1061.437%
Regen BioPharma, Inc. 149.61 Thousand USD -1061.437%
Affymax, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD -290.488%
CytoDyn Inc. 141 Thousand USD -1132.392%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -2072.091%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 77.779%
SYBLEU INC 300 Thousand USD -479.224%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD -370.852%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 78.679%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD -280.235%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD -49.67%
PureTech Health plc 18.25 Million USD 90.479%
Coeptis Therapeutics, Inc. 150 Thousand USD -1058.449%
IXICO plc 275 Thousand USD -531.881%
IntelGenx Technologies Corp. 11.83 Million USD 85.322%
Gelesis Holdings, Inc. 26.3 Million USD 93.395%
CSL Limited 11.23 Billion USD 99.985%
Cellectis S.A. 36.21 Million USD 95.201%